Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status Sort descending	Expiration Date	Program Official
Assay Validation of High Quality Markers for Clinical Studies in Cancer	PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed)	UH2, UH3	Clinical Trial Not Allowed	10/15/2026	Sudhir Srivastava, Ph.D., M.P.H.
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices	RFA-EB-22-002 (R18 Clinical Trial Not Allowed)	R18	Clinical Trial Not Allowed	06/18/2025	Rachel Altshuler, Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed)	R00, K99	Clinical Trial Not Allowed	10/15/2026	Jessica Faupel-Badger, Ph.D., M.P.H.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research	PAR-21-330 (U01 Clinical Trial Not Allowed)	U01	Clinical Trial Not Allowed	10/12/2024	Claire Zhu, Ph.D.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-009 (R33 Clinical Trial Not Allowed)	R33	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)	NOT-NS-20-107		Clinical Trial Not Allowed	05/16/2024	Brennan Streck, Ph.D., R.N., M.P.H.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-012 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-014 (P50 Clinical Trial Optional)	P50	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research	RFA-CA-24-013 (U01 Clinical Trial Optional)	U01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Consortium for Palliative Care Research Across the Lifespan	RFA-AG-25-002 (U54 Clinical Trial Optional)	U54	Clinical Trial Optional	07/03/2024	Brennan Streck, Ph.D., R.N., M.P.H.